Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Share News (PRM)

Share Price Information for Proteome (PRM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.05
Bid: 3.30
Ask: 4.80
Change: 0.19 (4.92%)
Spread: 1.50 (45.455%)
Open: 3.86
High: 0.00
Low: 0.00
Prev. Close: 3.86
PRM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS: G4S And Tullow Oil Lead FTSE 100 Gainers

Wed, 12th Nov 2014 12:02

LONDON (Alliance News) - The following stocks are amongst the biggest risers and fallers within the main London indices midday Wednesday.
-------
FTSE 100 WINNERS
-------
G4S, up 4.3%. The security company said organic revenue rose 4.2% in the first nine months of the year and it has agreed new contracts with annual revenues of over GBP870 million and total contract value of GBP1.7 billion. Contract retention for the nine months was similar to historical levels, at slightly above 90%, the company said.

Tullow Oil, up 1.5%. The oil explorer said it is reviewing its capital expenditure and costs, with overall exploration spending significantly reduced and focused primarily on East Africa where it has major basin-opening potential.
-------
FTSE 100 LOSERS
-------
Sainsbury's, down 5.4%. The supermarket operator swung to a pretax loss in the first half of the year, and outlined plans to cuts costs and capital expenditure. Pretax loss was GBP290 million for the 28 weeks to September 27 from a profit of GBP433 million in the same period a year earlier. First-half revenue fell 0.1% to GBP12.67 billion. It maintained its interim dividend, but its full-year dividend is expected to be cut.

Capita, down 5%. The outsourcing company said it has secured GBP1.63 billion of major sales so far this year, down from GBP2.9 billion in the same period last year when it had booked its largest ever contract worth GBP1.2 billion with O2.

SSE, down 2.7%. The utility reported a drop in pretax profit in the first half of the year due to warmer weather, lower electricity output and weak gas prices. For the six months ended September 30, pretax profit fell 6.2% to GBP316.6 million compared with GBP337.4 million a year earlier, mainly driven by a GBP22.1 million loss from its share of joint ventures.

Barclays, down 2%. The bank was among the five investigated by regulators over its FX dealings but remains in talks with regulators over its settlement. It has set aside GBP500 million in provisions to cover potential fines.

Burberry, down 1.2%. The luxury fashion retailer reported a 14% rise in underlying revenue of GBP1.1 billion but said it expects some pressure on full-year margin, a reflection of the strong pound, a more difficult external environment, and continued investments.

Royal Bank of Scotland, down 0.4%. The bank was one of five fined a total USD3.38 billion by UK, US and Swiss regulators for failings in its FX dealing operations. RBS was fined GBP399 million but said this is fully covered by provisions made in the third quarter.
-------
FTSE 250 WINNERS
-------
Essentra, up 2.5%. The company said it will buy the specialist packing arm of Clondalkin Group in a USD455 million deal, issuing shares to cover GBP160 million of the consideration. Clondalkin, which provides secondary packaging products for the pharmaceutical and healthcare industries, is owned by an affiliate of US private equity house Warburg Pincus and Essentra expects to complete the deal in the first quarter of 2015.

Moneysupermarket.com, up 2%. The price comparison website said it remains confident of meeting its expectations for the full year, after the "positive momentum and solid margins" seen in the third quarter continued through October. Third-quarter revenue rose by 18% year-on-year to GBP66.8 million, driven by increases in MoneySuperMarket.com, MoneySavingExpert.com, and TravelSupermarket.com, the company said
-------
FTSE 250 LOSERS
-------
SIG, down 7.5%. The building products distributor lowered its expectations for the year due to weak economic conditions in Europe, although it also raised its cost-benefit targets from the strategic initiatives it is taking.

Playtech, down 7.5%. Credit Suisse cut its rating on the stock to Underperform from Neutral and lowered its price target to 580 pence from 780p.

Diploma, down 1.6%. The company said Chairman John Rennocks is to step down from his role after the company's annual general meeting in January, appointing John Nicholas, currently a senior independent director on Diploma's board.
-------
AIM ALL-SHARE WINNERS
-------
Mountfield, up 8.1%. The company said its Connaught Access Flooring subsidiary has won a contract worth around GBP4.5 million to supply and install access flooring at a newly-built office development in the City of London. Work will start in January 2015 and is expected to be completed in the first quarter of 2016.

Solo Oil, up 7%. The company said it is awaiting formal approval from Tanzanian authorities for a deal that will see Solo buy a stake in the Kiliwani North Development license from Aminex, and the companies expect the deal to close shortly.
-------
AIM ALL-SHARE LOSERS
-------
Proteome Sciences, down 16%. The company said contract delays will mean its full-year revenue will come in below market expectations and lower than the revenue posted last year.

Quindell, down 9.6%. The company is understood to be on the brink of a formal probe by the City regulator over a share-transaction controversy which has caused its share price to plunge in the past week, the Daily Mail reported. The FCA declined to comment to Alliance News.

Physiomics, down 4%. The company posted a slightly narrowed loss in its year to end-June of GBP464,252, down from GBP543,791 a year before, as revenue rose to GBP267,903 from GBP240,000.
-------
By Ian Edmondson; ianedmondson@alliancenews.com;

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
25 Sep 2014 09:58

Proteome Unit Wins Alzheimer's Diagnostics Contract With Genting TauRx

Read more
8 Jul 2014 17:00

DIRECTOR DEALINGS: Proteome Sciences Non-Executive Buys Shares

Read more
8 Jul 2014 11:22

REPEAT: UK MIDDAY BRIEFING: M&S Online Sales Slump On Website Move

Read more
8 Jul 2014 11:19

UK MIDDAY BRIEFING: M&S Sales Slump On Website Move

Read more
8 Jul 2014 10:42

UK WINNERS & LOSERS: Airline Stocks Nosedive On Air France-KLM Warning

Read more
8 Jul 2014 08:45

UPDATE 1-Study paves way for simple blood test to predict Alzheimer's

* Fatal brain-wasting disease has no effective treatments * Experts say drug failures may be due to late trials * Predictive test could find people before disease sets in * Shares in Proteome Sciences, involved in work, jump 12 pct (Adds Proteome Sciences stock move) By

Read more
8 Jul 2014 08:26

Proteome Sciences Publishes Study For Alzheimer's Blood Test

Read more
29 May 2014 10:22

Proteome Sciences Confident For Revenue Growth As Loss Narrows

LONDON (Alliance News) - Proteome Sciences PLC Thursday expressed confidence for continued fast revenue growth for the "forseeable future", as it posted a narrowed pretax loss for 2013, driven by strong sales of its Tandem Mass Tag reagents and growth in its biomarker assays. Proteome is en

Read more
27 Mar 2014 14:08

Proteome Says Study Using SysQuant Technology Demonstrates Its Potential

LONDON (Alliance News) - Proteome Sciences PLC said Thursday that a study using its SysQuant technology to address pancreatic cancer published in medical journal PLOS ONE demonstrated the potential of proteomics to improve the way that bespoke treatments can be made to match patients. Prote

Read more
28 Feb 2014 16:18

XP Power board members reduce holdings

XP Power's Chairman, Larry Tracey, on Thursday sold 75,000 shares in the power supply solutions manufacturer. Tracey, who has held his current role since April 2002, disposed of the shares at 1,755p a time, generating a total of £1.3m. Fellow board member James Peters, a Non-Executive Director, t

Read more
24 Feb 2014 10:48

Proteome Sciences To Raise GBP5 Million In Share Placing

LONDON (Alliance News) - Proteome Sciences PLC said Monday it has placed 17.9 million new shares on the market to raise GBP5 million before expenses, with new and existing investors, which it will use for additional working capital. The protein biomarker company said the shares were placed

Read more
7 Feb 2014 10:06

Proteome edges ahead after flagging rise in revenue

Biotech group Proteome Sciences edged ahead after it revealed it expects revenue for 2013 to show "a significant increase" over 2012 thanks to strong performance across its core activities. The firm is an expert in biomarkers, or biological markers, that can help predict the likelihood of cancer r

Read more
7 Feb 2014 09:08

Proteome Sciences Says 2013 Revenues To Be Significantly Up

LONDON (Alliance News) - Shares in Proteome Sciences PLC rose in early trading Friday, after the protein biomarker company said revenue for 2013 will be significantly higher than the prior year, driven by a strong performance from all its core activities. Proteome is engaged in research an

Read more
4 Dec 2013 10:39

Proteome Sciences unveils sales delays, shares fall

Biotechnology group Proteome Sciences is facing sales delays that will push revenue from some deals into next year, hitting its shares. Proteome, which carries out research into protein and peptide biomarkers to treat neurological conditions and other illnesses such as cancer, said the timing and r

Read more
20 Nov 2013 10:55

Proteome Sciences Says Study Using Its Workflows Shows New Protein Biomarkers For Liver Cancer

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.